Glencore plc GLNCY · OTC
$14.26 -1.11% (-$0.16)
Summary
43 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 33% this fiscal year.
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- Earnings per share fell by 72% a year over the last 3 years.
- It cut its dividend by 23% last year.
- It reports a profit, yet spends more cash than it brings in.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.4 USD for 1 USD of yearly profit. Over the last five years it was 54.2 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it fell by 0.9% a year. For the next fiscal year analysts expect revenue to grow by 33%. Earnings per share fell by 72% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 97 USD
- Sales and administration 0.9 USD
- Taxes and other 0.7 USD
- Net profit 1.8 USD
Net profit, industry median (Industrial Materials) 11 USD
Out of every 100 USD of revenue, 1.8 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 4.77%
- Paid out of profit
- 74%
You receive $0.68 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 2
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $9.3 is 35% below today's price. 40% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.